Silvercrest Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRS
Silvercrest Asset Management's ATRS Position: Q2 2022 in Review
Silvercrest Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 2,372,497 shares — an estimated $9.73M sold.
Silvercrest Asset Management first reported a position in ATRS in Q3 2019 and held it in 11 quarters. The position peaked at $9.73M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Silvercrest Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Silvercrest Asset Management sold 2,372,497 Antares Pharma, Inc. shares in Q2 2022, an estimated $9.73M.
- Silvercrest Asset Management first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 11 quarters.
- Silvercrest Asset Management's Antares Pharma, Inc. position peaked at $9.73M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Silvercrest Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.